Efficacy and Safety of Dietary Therapies for Childhood Drug-Resistant Epilepsy
JAMA Pediatrics · 01.03.2023 · 177 (3) · 258
DOI: 10.1001/jamapediatrics.2022.5648 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift JAMA Pediatrics, erschienen am 01.03.2023. Verfasst von Nagita Devi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy Practice, National Institute of Pharmaceutical Education and Research (NIPER), S.A.S. Nagar, Punjab, India. Hauptthemen laut MEDLINE: Drug Resistant Epilepsy, Diet, Ketogenic, Diet, High-Protein Low-Carbohydrate. Die Arbeit wurde bisher 83-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Importance Despite advances in the understanding of dietary therapies in children with drug-resistant epilepsy, no quantitative comparison exists between different dietary interventions.
Objective
To evaluate the comparative efficacy and safety of various dietary therapies in childhood drug-resistant epilepsy. Data Sources Systematic review and network meta-analysis (frequentist) of studies in PubMed, Embase, Cochrane, and Ovid published from inception to April 2022 using the search terms ketogenic diet , medium chain triglyceride diet , modified Atkins diet , low glycemic index therapy , and refractory epilepsy . Study Selection Randomized clinical trials comparing different dietary therapies (ketogenic diet, modified Atkins diet, and low glycemic index therapy) with each other or care as usual in childhood drug-resistant epilepsy were included. Abstract, title, and full text were screened independently by 2 reviewers. Data Extraction and Synthesis Data extraction was conducted following Preferred Reporting Items for Systematic Reviews and Meta-analyses reporting guideline. Cochrane risk-of-bias tool was used to assess the study quality. Effect sizes were calculated as odds ratio with 95% CI using random-effects model. The hierarchy of competing interventions was defined using the surface under the cumulative ranking curve. Main Outcomes and Measures Short-term (≤3 months) 50% or higher and 90% or higher reduction in seizure frequency and treatment withdrawal due to adverse events were the primary efficacy and safety outcomes.
Results
Of 2158 citations, 12 randomized clinical trials (907 patients) qualified for inclusion. In the short term, all dietary interventions were more efficacious than care as usual for 50% or higher seizure reduction (low glycemic index therapy: odds ratio [OR], 24.7 [95% CI, 5.3-115.4]; modified Atkins diet: OR, 11.3 [95% CI, 5.1-25.1]; ketogenic diet: OR, 8.6 [95% CI, 3.7-20.0]), while ketogenic diet (OR, 6.5 [95% CI, 2.3-18.0]) and modified Atkins diet (OR, 5.1 [95% CI, 2.2-12.0]) were better than care as usual for seizure reduction of 90% or higher. However, adverse event–related discontinuation rates were significantly higher for ketogenic diet (OR, 8.6 [95% CI, 1.8-40.6]) and modified Atkins diet (OR, 6.5 [95% CI, 1.4-31.2]) compared with care as usual. Indirectly, there was no significant difference between dietary therapies in efficacy and safety outcomes. Conclusions and Relevance This study found that all dietary therapies are effective in the short term. However, modified Atkins diet had better tolerability, higher probability for 50% or higher seizure reduction, and comparable probability for 90% or higher seizure reduction and may be a sounder option than ketogenic diet. Direct head-to-head comparison studies are needed to confirm these findings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Pharmacy Practice, National Institute of Pharmaceutical Education and Research (NIPER), S.A.S. Nagar, Punjab, India.
- Department of Pediatrics (Pediatric Neurology), Amrita Institute of Medical Sciences, Faridabad, Haryana, India.
- Pediatric Neurology Unit, Advanced Pediatric Center, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
Zitieren
APA
Devi, N., Madaan, P., Kandoth, N., Bansal, D., & Sahu, J. K. (2023). Efficacy and Safety of Dietary Therapies for Childhood Drug-Resistant Epilepsy. JAMA Pediatrics, 177(3), 258. https://doi.org/10.1001/jamapediatrics.2022.5648
Vancouver
Devi N, Madaan P, Kandoth N, Bansal D, Sahu JK. Efficacy and Safety of Dietary Therapies for Childhood Drug-Resistant Epilepsy. JAMA Pediatrics. 2023;177(3):258. doi:10.1001/jamapediatrics.2022.5648
BibTeX
@article{Devi2023,
author = {Devi, Nagita and Madaan, Priyanka and Kandoth, Nidhun and Bansal, Dipika and Sahu, Jitendra Kumar},
title = {Efficacy and Safety of Dietary Therapies for Childhood Drug-Resistant Epilepsy},
journal = {JAMA Pediatrics},
year = {2023},
volume = {177},
number = {3},
pages = {258},
doi = {10.1001/jamapediatrics.2022.5648}
}
EUVIMED